ArticleMolecular therapy. Nucleic acids2020

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.

Cheng-Han Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.